Trends

Top 30 Biotech Startups and Scaleups in Boston

Post by
Top 30 Biotech Startups and Scaleups in Boston

The biomedical and pharmaceutical industry in Boston is booming. In recent years, the city has seen an influx of biotech startups and scaleups, many of which are revolutionizing the healthcare landscape.

In this blog post, we will be taking a look at the top 30 biotech startups and scaleups in Boston. These companies are changing the way we think about and approach healthcare.

So without further ado, let's take a look at the top 30 biotech startups and scaleups in Boston.

1- Sophia Genetics 

Year Founded- 2011

Location- Boston, MA

CEO- Dr. Jurgi Camblog

SOPHiA GENETICS is a biotechnology company that seeks to assist healthcare practitioners by using the power of data-driven medicine to its fullest potential.

Credit Suisse and Hitachi Ventures are two notable investors in SOPHiA GENETICS.

On October 1, 2020, SOPHiA GENETICS finalized their recent investment round from a Series F round.

2- Path AI

Year Founded- 2016

Location- Boston, MA

CEO- Andy Beck

PathAI is developing a technology that lets pathologists diagnose each patient quickly and precisely.

General Atlantic and LabCorp are two notable PathAI investors.

On May 18, 2021, PathAI completed its recent Series C round.

3- Podimetrics

Year Founded- 2011

Location- Boston, MA

CEO- Jon Bloom

Podimetrics is a virtual care management organization whose goal is to stop dangerous and expensive diabetes amputations. Through agreements with payers and at-risk providers, such as the Veterans Health Administration, they offer our FDA-cleared SmartMatTM to high-risk patients.

The two prominent investors in Podimetrics are Polaris Partners and D1 Capital Partners.

On March 24, 2022, Podimetrics closed its recent Series C investment.

4- Aetion

Year Founded- 2013

Location- Boston, MA

CEO- Carolyn Magill

Aetion offers life science enterprises and payers real-world evidence (RWE) and outcomes-based analytics solutions.

The two notable investors in Aetion are Warburg Pincus and B Capital Group.

On May 11, 2021, Aetion completed its recent round of fundraising from a Series C round.

5- Reverie Labs

Year Founded- 2017

Location- Boston, MA

CEO- Jonah Kallenbach

Using computation, Reverie Labs (YC W18) is creating a pharmaceutical company from scratch. Reverie Labs uses machine learning to optimize lead generation and accelerate preclinical drug development.

On February 3, 2021, Reverie Labs closed its recent Series A round.

Significant investors in this startup include Neo and Ridgeback Capital.

6- Tempus

Year Founded- 2015

Location- Boston, MA

CEO- Eric Lefkofsky

Biotech firm Tempus is developing the greatest library of molecular and clinical data in the world as well as an operating system to make the data available and useful.

The recent round of debt financing for Tempus was completed on December 10, 2020.

Significant investors in this startup include T. Rowe Price and Baillie Gifford.

7- Biofourmis

Year Founded- 2015

Location- Boston, MA

CEO- Kuldeep Rajput

Biofourmis is a biotech startup that uses digital pharmaceuticals to provide tailored care and therapies. In order to improve patient outcomes, the company finds, creates, and distributes scientifically validated software-based treatments. Personalized treatment can be provided by physicians using cutting-edge techniques, and payers can also use cost-effective alternatives.

Biofourmis completed its recent investment round from a Series D round on July 27, 2022.

Intel Capital and CVSHealth have both made large investments in this firm.

8- Akili Interactive Labs

Year Founded- 2011

Location- Boston, MA

CEO- Eddie Martucci

Akili Interactive Labs creates interactive VR experiences by fusing neuroscience understanding with gaming technology. These experiences are intended to aid in the treatment of cognitive problems and the development of therapies unique to the requirements of each patient. Their technology can support and treat people with ADHD, MDD, and ASD by giving them access to gamified technologies that can aid them with their attention problems and cognitive impairments.

On May 26, 2021, Akili Interactive Labs closed their recent funding from a Series D round.

Omidyar Network and Fearless Ventures are two important investors in this firm.

9- Ginko Bioworks

Year Founded- 2008

Location- Boston, MA

CEO- Jason Kelly

Ginkgo Bioworks is a biotech startup. It creates items for biological engineering and unique microorganisms for various markets. It creates, develops, tests, and licenses organisms through engineering. In tastes, sweeteners, cosmetic components, agricultural treatments, and medications, it finds compounds. It also produces libraries of chemicals and offers probiotic bacteria to shield the body from harmful illnesses. It supports the markets for probiotics, natural product development, carbon mitigation, and cultured components.

On June 1, 2020, Ginkgo Bioworks completed its recent investment round from a Series B round.

Viking Global Investors and Empede Capital are two important investors in this firm.

10- Emulate

Year Founded- 2014

Location- Boston, MA

CEO- Jim Corbett

Emulate is a biotech startup that develops cutting-edge in vitro models for figuring out how illnesses, medications, pollutants, and foods affect people's health.

On September 7, 2021, Emulate closed its recent round of fundraising from a Series E round.

Perceptive Advisors and Northpond Ventures are two important investors in this firm.

11- inviCRO

Year Founded- 2008

Location- Boston, MA

CEO- Matt Silva

inviCRO is a biotech startup that provides complete tissue-to-human imaging, analysis, and data management services.

On February 19, 2016, inviCRO completed its recent round of investment from a private equity round.

12- Pear Therapeutics

Year Founded- 2013

Location- Boston, MA

CEO- Corey Mccann

Pear Therapeutics is a digital therapeutics platform based on software that aims to improve the effectiveness of drugs while treating disease.

On December 3, 2021, Pear Therapeutics completed its recent investment round, which was a Post-IPO Equity transaction.

Pritzker/Vlock Family Office and Trustbridge Partners are two important investors in this startup.

13- Juno Therapeutics

Year Founded- 2013

Location- Boston, MA

Juno Therapeutics is a clinical-stage startup that creates immunotherapies for the cure of cancer.

On August 5, 2014, Juno Therapeutics closed its recent investment round from a Series B round.

Bezos Expeditions and ARCH Venture Partners are two important investors in this firm.

14- Wave Life Sciences

Year Founded- 2012

Location- Boston, MA

CEO- Paul Bolno

Wave Life Sciences is a genetic medicine company in the clinical stages that is dedicated to providing patients with life-altering therapies for fatal diseases.

On February 20, 2018, Wave Life Sciences finalized its most recent investment round from a Post-IPO Equity round.

Takeda Ventures and Teva Pharmaceutical Industries are important investors of this firm.

15- Paratek Pharmaceuticals

Year Founded- 1996

Location- Boston, MA

CEO- Evan Loh

Dedicated to the creation and marketing of cutting-edge treatments, Paratek Pharmaceuticals is a biopharmaceutical firm.

On April 1, 2020, a Post-IPO Equity round of financing for Paratek Pharmaceuticals came to an end.

Biomedical Advanced Research and Development Authority (BARDA) and Omega Funds are significant investors of this firm.

16- Akouos

Year Founded- 2017

Location- Boston, MA

CEO- Manny Simons

The biotechnology startup Akouos is dedicated to maintaining and repairing hearing. The company uses adeno-associated viral (AAV) vector-based gene therapy to restore and preserve hearing in genetically defined patient populations in a variety of forms, from a single genetic mutation to ototoxic drug exposure and the aging process, allowing the medical field to effectively treat sensorineural hearing loss.

On March 3, 2020, Akouos completed its recent Series B round of fundraising.

This company has large investments from PAG and Fidelity Management and Research Company.

17- Life Biosciences

Year Founded- 2017

Location- Boston, MA

CEO- Jerry Mclaughlin

The biotech startup Life Biosciences creates medications to extend the life and find cures for age-related illnesses.

On January 5, 2022, Life Biosciences closed its recent investment round from a Series C round.

Significant investors in this business include George Godula and Alpha Wave Ventures.

18- WeGo Health

Year Founded- 2007

Location- Boston, MA

CEO- Jack Barrette

In order to provide more individuals with access to their therapies, WEGO Health collaborates with pharmaceutical firms and healthcare institutions. 

The business provides a platform modeled after an influencer that businesses can utilize to distribute their messages and promote their goods. With the use of their technology, companies may track user interaction and learn more about the perspectives and attitudes of patients in order to inform future research.

19- Adeo Health Science

Year Founded- 2015

Location- Boston, MA

CEO- Clarence Friedman

Adeo Health Science is a biotech startup that sells organic foods. The company's purpose is to translate the most recent findings in food allergy prevention research into family-friendly, organic goods that can be trusted. 

On January 1, 2018, Adeo Health Science closed its latest round of fundraising from a Venture - Series Unknown round.

Both MassChallenge and Crimson Seed Capital have invested in this business.

20- Vertex Pharmaceuticals

Year Founded- 1989

Location- Boston, MA

CEO- Reshma Kewalramani

For the treatment of severe disorders, Vertex Pharmaceuticals focuses on the discovery and development of small molecule medicines.

On May 17, 2022, Vertex Pharmaceuticals completed its recent Post-IPO Equity financing round.

The two significant investors in this startup are J.P. Morgan Securities Inc. and Bank of America Merrill Lynch.

21- ElevateBio

Year Founded- 2017

Location- Boston, MA

CEO- David Hallal

ElevateBio is a biotech startup that focuses on cell- and gene-based therapeutics.

In total, ElevateBio has raised $845M in investment over 4 stages. A Series C round of funding was received by them on March 15, 2021.

The newest investors of ElevateBio include EDBI and Emerson Collective.

22- Laronde

Year Founded- 2017

Location- Boston, MA

CEO- John Mendlien

Laronde creates a therapeutic platform based on eRNA that can identify various proteins throughout the body. It is long-lasting, non-immunogenic, repeatable, and flexible in terms of composition and distribution.

On August 30, 2021, Laronde closed its recent round of fundraising from a Series B round.

Two prominent investors in this startup are BlackRock and Invus.

23- Neumora Therapeutics

Year Founded- 2019

Location- Boston, MA

CEO- Paul Berns

As a clinical-stage biotechnology startup, Neumora Therapeutics is a leader in developing precision medications for brain disorders by fusing data science and neuroscience.

On October 7, 2021, Neumora Therapeutics closed its recent round of fundraising from a Series A round.

The two prominent investors in this startup are Newpath Management and Amgen.

24- Tessera Therapeutics

Year Founded- 2018

Location- Boston, MA

CEO- Michael Severino

Tessera Therapeutics is a biotech startup that specializes in a brand-new class of genetic drugs.

On April 19, 2022, Tessera Therapeutics closed its recent investment round from a Series C round.

The startup's two notable backers are CDH Investments and Longevity Vision Fund.

25- Xtalpi

Year Founded- 2014

Location- Boston, MA

CEO- Ma Jian

With its Intelligent Digital Drug Discovery and Development (ID4) platform, the pharmaceutical technology company XtalPi is revolutionizing how the industry conducts drug research and development. 

The ID4 platform gives pharmaceutical businesses the ability to improve their efficiency, accuracy, and success rate at crucial stages of medication R&D through the tightly interwoven use of quantum mechanics, artificial intelligence, and high-performance cloud computing algorithms. 

XtalPi seeks to promote global health by quickening the pace of drug discovery and development.

26- Nirrin

Year Founded- 2018

Location- Boston, MA

CEO- Jonathan Hartmann

Nirrin is a biotech startup that creates technologies for non-destructively monitoring real-time bioprocesses. It offers the biopharmaceutical and life science sectors better process control, quicker process development, and adaptive manufacturing.

On October 19, 2021, Nirrin Technologies announced the completion of its recent investment round, which was a Venture - Series Unknown round.

27- Seven Bridges

Year Founded- 2014

Location- Boston, MA

CEO- William Moss

Seven Bridges is a market-leading infrastructure and data analytics business, which makes it possible to comprehend biomedical data.

On April 27, 2021, a Series C round of money was used to close up Seven Bridges' recent funding round.

There are two notable investors in this startup: Kryssen Capital and First Star Ventures.

28- IDRx

Year Founded- 2014

Location- Boston, MA

CEO- Ben Auspitz

IDRx is a biotech startup in the clinical stages that is committed to revolutionizing cancer treatment with carefully thought-out precision combination treatments.

On August 2, 2022, Idrx completed its recent round of fundraising from a Series A investment.

Two notable investors in this startup are Casdin Capital and Forge Life Science Partners.

29- Cellink

Year Founded- 2016

Location- Boston, MA

CEO- Erik Gatenholm

Cellink is a biotech startup that has developed a bench-top bioprinter that is best suited for producing human tissues.

On March 4, 2020, Cellink closed its recent round of grant funding.

The two notable investors in Cellink are Vinnova and EASME, the EU Executive Agency for SMEs.

30- Orna Therapeutics

Year Founded- 2019

Location- Boston, MA

CEO- Thomas Barnes

Orna Therapeutics is a biotech startup that focuses on fully designed circular RNA therapeutics to address various ailments.

On August 16, 2022, Orna Therapeutics closed its recent Series B round.

Orna Therapeutics has two notable investors: MPM Capital and BioImpact.

Scispot is becoming the go-to operating platform for biostartups in Boston. Scispot combines the critical functionalities of electronic lab notebooks (ELNs) and lab information management systems (LIMS) into one user-intuitive platform and helps biostartups accelerate their R&D and bring their scientific breakthroughs to market faster. 

Request a demo to learn how you can accelerate your research and automate lab workflows using Scispot.

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.